NCT02622009

Brief Summary

Background: The presence of low-grade viral infection in the airways of patients with stable chronic obstructive pulmonary disease (COPD) could potentially have implications in the pathogenesis and progression of the disease, but previous studies have reported very different rates of human rhinovirus (HRV) and respiratory syncytial virus (RSV) genome detection in nasal and sputum samples. However, no study has investigated the presence of these viruses directly in the lungs by bronchoalveolar lavage (BAL) and bronchial biopsies. This study aimed to investigate whether HRV and RSV are present in the lungs of stable COPD patients by performing BAL and bronchial biopsies, and relate their presence with disease severity. Methods: Consecutive patients with stable COPD and control subjects, who underwent diagnostic (e.g., lung cancer) and/or therapeutic (e.g., hemoptysis) fibreoptic bronchoscopy in a university hospital in Athens, Greece, were enrolled. The collected BAL and bronchial biopsies during bronchoscopy were subsequently processed for HRV and RSV RNA detection with real-time polymerase chain reaction (PCR). More specifically, the nucleocapsid gene and 5΄ non-coding region were searched for RSV and HRV detection, respectively.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
53

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2010

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

December 2, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 4, 2015

Completed
Last Updated

December 7, 2015

Status Verified

December 1, 2015

Enrollment Period

4 years

First QC Date

December 2, 2015

Last Update Submit

December 4, 2015

Conditions

Keywords

stable COPD; bronchoalveolar lavage; biopsy; HRV; RSV

Outcome Measures

Primary Outcomes (1)

  • HRV AND RSV PRESENCE

    A Nucleocapsid (N) gene partial sequence, as well as a 5΄ non-coding region (5΄NCR) partial sequence were amplified for RSV and HRV, respectively.

    7 days

Study Arms (5)

COPD I

BRONCHOSCOPIC PROCEDURE IN COPD PATIENTS STAGE I

Procedure: BRONCHOSCOPIC PROCEDURE

COPD II

BRONCHOSCOPIC PROCEDURE IN COPD PATIENTS STAGE II

Procedure: BRONCHOSCOPIC PROCEDURE

COPD III

BRONCHOSCOPIC PROCEDURE IN COPD PATIENTS STAGE III

Procedure: BRONCHOSCOPIC PROCEDURE

NONSMOKERS

BRONCHOSCOPIC PROCEDURE IN NONSMOKERS

Procedure: BRONCHOSCOPIC PROCEDURE

CURRENT OR EXSMOKERS

BRONCHOSCOPIC PROCEDURE IN CURRENT OR EXSMOKERS

Procedure: BRONCHOSCOPIC PROCEDURE

Interventions

After the routine bronchoscopic inspection of the tracheobronchial tree, the investigators performed BAL from subsegmental bronchi and bronchial biopsies (3-4 per patient) from non infiltrated carina

COPD ICOPD IICOPD IIICURRENT OR EXSMOKERSNONSMOKERS

Eligibility Criteria

Age51 Years - 76 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

We enrolled 31 patients with COPD and 22 control subjects. The most common symptoms were dyspnea (32%), cough (19%) and hemoptysis (13%). Whereas 47% of participants did not mention any symptom, but referred to our department in order to investigate bronchoscopically abnormal radiographic findings revealed in chest computed tomography. The commonest comorbidities of COPD patients were arterial hypertension (47%), hyperlipidemia (20.7%) and coronary artery disease (17%), and of control subjects arterial hypertension (50%), hyperlipidemia (22,7%) and diabetes mellitus type 2 (13,6%).

You may qualify if:

  • stable COPD,indication for bronchoscopic procedure

You may not qualify if:

  • atopic history, asthma, extensive pleural effusions, bronchiectasis, immunosuppression due to chemotherapy or systemic corticosteroids and all the contraindications of the bronchoscopic procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Mar 15;173(6):639-43. doi: 10.1164/rccm.200510-1681OC. Epub 2005 Dec 30.

    PMID: 16387798BACKGROUND
  • Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001 Nov 1;164(9):1618-23. doi: 10.1164/ajrccm.164.9.2105011.

    PMID: 11719299BACKGROUND
  • Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 May 1;173(9):991-8. doi: 10.1164/rccm.200509-1525OC. Epub 2006 Feb 10.

    PMID: 16474030BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

BAL and bronchial biopsies

MeSH Terms

Interventions

Bronchoscopy

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Respiratory SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativePulmonary Surgical ProceduresThoracic Surgical Procedures

Study Officials

  • GEORGIOS ARSENIS, PROFESSOR

    University of Athens

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident in Respiratory Medicine

Study Record Dates

First Submitted

December 2, 2015

First Posted

December 4, 2015

Study Start

November 1, 2010

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

December 7, 2015

Record last verified: 2015-12

Data Sharing

IPD Sharing
Will not share